Funded Tech Companies
Vico Therapeutics
Wondering who invested in Vico Therapeutics? Polaris Partners, Ackermans & Van Haaren and Droia Ventures invested in this biopharmaceutical company.
Company Overview
Company Name
Vico Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
BioScience Park BioPartner Building 1 J.H. Oortweg 21
Leiden, 2333 CH
The Netherlands
Leiden, 2333 CH
The Netherlands
Phone
Website
Email Address
Company Background Information
Overview
Vico Therapeutics is a clinical-stage genetic medicines company developing antisense oligonucleotide (ASO) RNA modulating therapies for patients with severe neurological diseases. Our lead product candidate, VO659, is currently in Phase 1/2a clinical development for the treatment of spinocerebellar ataxia types 3 and 1 and Huntington's disease and is the only ASO in the clinic that targets the underlying CAG repeat expansions that cause all nine known polyglutamine diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/5/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Micah Mackison
Chief Medical Officer
Scott Schobel
Chief Scientific Officer
Nicole Datson
Company Investors
- Polaris Partners
- Ackermans & Van Haaren
- Droia Ventures
- Eurazeo
- Kurma Partners
- Pureos Bioventures
- EQT Life Sciences
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs